Evaluation of Maximum Residue Limits for Veterinary Drug Residues: Standards, Testing, and Complianc

Maximum residue limit (MRL) evaluation for veterinary drug residues is a critical food safety discipline that determines whether foods of animal origin — meat, milk, eggs, honey, and aquatic products — comply with the legal residue thresholds established by national and international regulations. This article provides a comprehensive technical overview of MRL standards such as GB 31650, EU Regulation No 37/2010, Codex Alimentarius limits, and US tolerance regulations, along with the sample matrices, analyte classes, analytical methods, and validation criteria used in professional residue compliance assessment by accredited third-party laboratories.

Technical Overview

A maximum residue limit (MRL) is the maximum concentration of a veterinary pharmacologically active substance, expressed in mg/kg or µg/kg, that is legally permitted in a specified food commodity of animal origin. The limit is defined for the marker residue — the residue whose concentration has a known relationship to the total residue of toxicological concern in the target tissue. MRLs are derived from toxicological and pharmacological evaluations, the acceptable daily intake (ADI), residue depletion studies in the target animal species, and the calculated withdrawal period required for residues to fall below the legal threshold.

Because MRLs differ by jurisdiction, commodity, tissue, and substance, a professional evaluation must identify the applicable regulatory framework before analytical results can be interpreted. The principal reference systems include:

• China: GB 31650-2019 "National Food Safety Standard — Maximum Residue Limits for Veterinary Drugs in Foods" and its supplement GB 31650.1, supported by GB and GB/T method standards and the GB 31660 series of determination methods.
• European Union: Commission Regulation (EU) No 37/2010 establishing MRLs for pharmacologically active substances, with analytical performance criteria governed by Commission Implementing Regulation (EU) 2021/808.
• United States: tolerances for drug residues in edible tissues set under 21 CFR Part 556.
• Codex Alimentarius: CAC/MRL 2, the internationally harmonized MRL schedule used to resolve trade disputes.
• Japan: the positive list system, which assigns default limits (nominally 0.01 mg/kg) to substances without established MRLs.

An MRL assessment typically concludes with a pass/fail conformity statement for each drug–matrix pair, including identification of prohibited substances for which no residue is permitted at any detectable concentration. Such evaluations are routinely performed by accredited third-party laboratories operating under ISO/IEC 17025 quality management systems.

Testing Samples

Edible Tissues of Livestock and Poultry

The four regulatory target matrices — muscle, liver, kidney, and fat (with or without skin for poultry and fish) — are the primary samples for residue control, because MRLs are set tissue-by-tissue. Liver and kidney are metabolically active and frequently carry the highest residue burdens, making them the most sensitive indicator matrices in surveillance programs for cattle, swine, sheep, goats, poultry, and rabbits.

Milk and Dairy Products

Raw milk at the farm or processing-plant level is monitored for lipophilic and hydrophilic drug residues, particularly beta-lactam antibiotics and sulfonamides, which are the leading causes of milk rejections in the dairy industry. Processed dairy matrices such as milk powder, butter, and cheese may require matrix-specific extraction procedures.

Eggs and Egg Products

Whole egg is the reference matrix for layer-hen medication control. Lipophilic drugs such as macrolides, tetracyclines, and certain anticoccidials partition into egg yolk and can persist after treatment, so both yolk and whole-egg homogenates may be analyzed.

Aquatic Products

Fish muscle (with or without skin, as specified by the applicable standard), shrimp, crab, and shellfish are analyzed for aquaculture-associated residues including fluoroquinolones, malachite green, leucomalachite green, nitrofurans, and chloramphenicol. Export consignments are subject to particularly stringent residue screening.

Honey and Other Apiary Products

Honey is monitored for tetracyclines, sulfonamides, streptomycin, and nitrofuran metabolites used historically against foulbrood disease. The complex sugar matrix requires dedicated cleanup prior to instrumental quantification.

Support Matrices

• Animal feed, for carry-over and cross-contamination assessment.
• Animal urine and blood plasma, for on-farm rapid screening and live-animal testing.
• Water from aquaculture systems, where residue persistence affects withdrawal decisions.

Testing Items

Residue evaluation covers all major pharmacological classes, with analyte scope defined by the applicable MRL schedule. Typical categories include:

• Antibacterials — tetracyclines: oxytetracycline, tetracycline, chlortetracycline, doxycycline, including 4-epimer forms where required by the residue definition.
• Antibacterials — beta-lactams: penicillin G, amoxicillin, ampicillin, cloxacillin, ceftiofur, and cephalosporin metabolites.
• Antibacterials — macrolides and lincosamides: erythromycin, tylosin, tilmicosin, tulathromycin, spiramycin, lincomycin.
• Antibacterials — aminoglycosides: gentamicin, streptomycin, dihydrostreptomycin, neomycin, spectinomycin.
• Antibacterials — sulfonamides and trimethoprim: sulfadiazine, sulfamethazine, sulfadimethoxine, sulfaquinoxaline, and related compounds.
• Antibacterials — (fluoro)quinolones: enrofloxacin and ciprofloxacin (summed where defined), danofloxacin, marbofloxacin, flumequine, oxolinic acid, nalidixic acid.
• Amphenicols: florfenicol and florfenicol amine, thiamphenicol.
• Antiparasitics: avermectins (ivermectin, abamectin, doramectin), benzimidazoles (albendazole, fenbendazole and metabolites, oxfendazole), levamisole, and organophosphate compounds.
• Anticoccidials: ionophores (monensin, salinomycin, lasalocid), nicarbazin, toltrazuril, diclazuril, and decoquinate.
• Sedatives and anti-inflammatory agents: xylazine, azaperone, carazolol, plus NSAIDs such as flunixin, meloxicam, and diclofenac where registered.
• Prohibited substances (zero tolerance): chloramphenicol, nitrofuran metabolites (AOZ, AMOZ, SEM, AHD), malachite green and leucomalachite green, clenbuterol and other beta-agonists, and certain hormonally active growth promoters. These are assessed against reference points for action or minimum required performance limits rather than MRLs.

Testing Methods

Confirmatory Chromatographic Analysis

Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is the gold-standard confirmatory technique, enabling simultaneous quantification of tens to hundreds of analytes across residue classes at sub-µg/kg levels. GC-MS and GC-MS/MS are applied to volatile or derivatized analytes, while HPLC with UV, fluorescence, or diode-array detection remains valid for high-concentration single-class determinations. Method performance and identification criteria (ion ratios, retention time, mass accuracy) are governed by regulations such as EU Implementing Regulation 2021/808, with decision limit (CCα) and detection capability (CCβ) established during validation.

Screening Methods

• Enzyme-linked immunosorbent assay (ELISA) and lateral-flow immunoassays for rapid class-level screening of beta-lactams, sulfonamides, and quinolones in milk and urine.
• Microbiological inhibition assays (e.g., plate tests) as broad-spectrum antibacterial screens in muscle and kidney.
• Biosensor and receptor-based assays for high-throughput pre-screening of tank milk and slaughter samples.

Sample Preparation

Extraction typically employs acidified organic solvents, QuEChERS-based protocols consistent with the EN 15662 approach, or matrix solid-phase dispersion, followed by cleanup using solid-phase extraction (SPE) cartridges. Nitrofuran analysis requires acid hydrolysis and derivatization of the tissue-bound metabolites before LC-MS/MS measurement, since the parent drugs are rapidly degraded in vivo.

Quality Assurance and Validation

Accredited third-party laboratories validate methods for specificity, linearity, recovery (typically 70–120%), repeatability and reproducibility, limits of detection and quantification, and measurement uncertainty, all within an ISO/IEC 17025 management framework. Matrix-matched calibration, isotope-labeled internal standards, and certified reference materials are used to ensure traceable, defensible results for regulatory decision-making.

Applications

MRL compliance evaluation supports multiple stakeholders across the food and agri-business value chain:

• Export and import control: demonstrating conformity with destination-market requirements (GB standards for China, EU Regulation 37/2010, 21 CFR 556 tolerances, Japanese positive list, Codex limits) and supporting customs clearance.
• Regulatory surveillance: national residue monitoring plans covering scheduled sampling of tissues, milk, eggs, and honey at slaughterhouses and collection points.
• Farm and producer quality assurance: verification of withdrawal-period compliance after treatment, pre-slaughter clearance testing, and root-cause investigation of positive findings.
• Food industry incoming inspection: supplier qualification and raw-material acceptance testing for dairy, meat, egg, honey, and seafood processors operating HACCP-based systems.
• Aquaculture and apiculture management: residue control in farmed fish, shrimp, and bee colonies to protect brand integrity and market access.
• Risk assessment and research: dietary exposure modelling against ADI values, depletion-kinetics studies, and support for new veterinary drug registration dossiers.

FAQ

What is the difference between an MRL and a tolerance? An MRL (used by Codex, the EU, and China) and a tolerance (used in United States regulation under 21 CFR Part 556) are conceptually equivalent: both define the maximum legally permitted residue concentration in a defined food commodity. The terminology and numerical values differ between jurisdictions, so the applicable market's framework must always be specified.

What is a marker residue? The marker residue is the specific compound (parent drug or metabolite) whose concentration in the target tissue is used to monitor total residues of toxicological concern. Some residue definitions require the sum of related compounds — for example, enrofloxacin plus ciprofloxacin, or tetracyclines including their 4-epimers — which analytical methods must reflect.

How are results for prohibited drugs evaluated if no MRL exists? Substances such as chloramphenicol, nitrofuran metabolites, malachite green, and beta-agonists are banned in food-producing animals in most jurisdictions. Any confirmed detection above the analytical reference point for action (RPA) or minimum required performance limit renders the lot non-compliant, which is why confirmatory methods with LOQs at or below 0.1–0.5 µg/kg are required.

Which standard applies in China? GB 31650-2019, together with its supplementary part GB 31650.1, establishes the permitted MRLs, while determination is performed using the corresponding GB, GB/T, and GB 31660 series method standards. Products traded internationally are additionally assessed against the destination market's limits, which may be stricter.

What sample condition and quantity are required? Typically 200–500 g of chilled or frozen homogenized tissue, or an equivalent volume of milk, egg, or honey, is submitted with full traceability documentation. Samples should be kept cold during transport, and freeze-thaw cycles avoided to preserve labile residues such as tetracyclines.

How long does a full MRL assessment take? Screening-level results are often available within 3–5 working days, while multi-class LC-MS/MS confirmation and full reporting generally require 7–10 working days depending on the analyte scope, matrix complexity, and any confirmatory re-testing triggered by initial positive findings.